Interplay of antibiotics and bacterial inoculum on suture-associated biofilms
- PMID: 22682712
- PMCID: PMC3498097
- DOI: 10.1016/j.jss.2012.04.040
Interplay of antibiotics and bacterial inoculum on suture-associated biofilms
Abstract
Background: Biofilms are often antibiotic resistant, and it is unclear if prophylactic antibiotics can effectively prevent biofilm formation. Experiments were designed to test the ability of high (bactericidal) concentrations of ampicillin (AMP), vancomycin (VAN), and oxacillin (OXA) to prevent formation of suture-associated biofilms initiated with low (10(4)) and high (10(7)) numbers of Staphylococcus aureus.
Materials and methods: S. aureus biofilms were cultivated overnight on silk suture incubated in biofilm growth medium supplemented with bactericidal concentrations of AMP, VAN, or OXA. Standard microbiological methods were used to quantify total numbers of viable suture-associated S. aureus. Crystal violet staining followed by spectroscopy was used to quantify biofilm biomass, which includes bacterial cells plus matrix components. To observe the effects of antibiotics on the microscopic appearance of biofilm formation, biofilms were cultivated on glass slides, then stained with fluorescent dyes, and observed by confocal microscopy.
Results: In the presence of a relatively low inoculum (10(4)) of S. aureus cells, bactericidal concentrations of AMP, VAN, or OXA were effective in preventing development of suture-associated biofilms. However, similar concentrations of these antibiotics were typically ineffective in preventing biofilm development on sutures inoculated with 10(7)S. aureus, a concentration relevant to contaminated skin. Confocal microscopy confirmed that bactericidal concentrations of AMP, VAN, or OXA inhibited, but did not prevent, development of S. aureus biofilms.
Conclusion: Bactericidal concentrations of AMP, VAN, or OXA inhibited formation of suture-associated biofilms initiated with low numbers (10(4)), but not high numbers (10(7)), of S. aureus cells.
Copyright © 2012. Published by Elsevier Inc.
Figures
References
-
- Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 2005;13:34. - PubMed
-
- Cogan NG, Gunn JS, Wozniak DJ. Biofilms and infectious diseases: biology to mathematics and back again. FEMS Microbiol Lett. 2011;322:1. - PubMed
-
- Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11:1034. - PubMed
-
- Cos P, Tote K, Horemans T, et al. Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des. 2010;16:2279. - PubMed
-
- Monds RD, O’Toole GA. The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends Microbiol. 2009;17:73. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
